The Sanofi drug, known as fitusiran and now Qfitlia, was approved on Friday for a broad group of people with the rare ...
A new study conducted by researchers at Hokkaido University has unveiled a novel class of zwitterionic phospholipids capable ...
Two molecular control factors play a decisive role in what is known as splicing, the cutting and assembly of mature messenger ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback